Summary
- Current Price
- As of today, OTLK price is $0.23, up +2.03% in the most recent trading session on
- Current Price All-Time High
- OTLK price is currently -99.97% below its historical high of $878.40 set on
- Market Cap
- OTLK current market cap is $27M, down -45.85% year-over-year
- PE Ratio
- OTLK PE ratio is unknown
- Revenue
- OTLK current annual revenue is $1.41M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for OTLK is on
Profile
| Metric | Value |
|---|---|
| Full Name | Outlook Therapeutics, Inc. |
| Ticker | NASDAQ: OTLK |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | outlooktherapeutics.com |
| Employees | 23 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.23 | ||
| Price, 1D Change | +2.03% | |
| $27M | ||
| - | ||
| - | ||
| 1.53 | ||
| $1M | ||
| Revenue, 1Y Change | +100.00% | |
| -$1.79 | ||
| EPS, 1Y Change | +55.85% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ONS | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.79 | ||
| EPS Estimate | N/A | -$0.51 |
| EPS Est. Change | N/A | +71.76% |
| $1.41M | ||
| Revenue Estimate | N/A | $21.22M |
| Revenue Est. Change | N/A | +1,401.00% |
| $0.23 | ||
| Price Target | - | $6.00 |
| Price Tgt. Change | - | +2,557.22% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.01 | -$4.06 | -1.33% | |
| -$1.84 | -$1.79 | +2.37% | |
| -$0.51 | N/A | +71.76% | |
| -$0.27 | N/A | +85.13% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $6.72M | $1.41M | -78.96% | |
| $21.22M | N/A | +1,401.00% | |
| $57.97M | N/A | +4,001.17% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -85.24% | ||
| -99.00% | ||
| -45.85% | ||
| -90.60% | ||
| +100.00% | ||
| +100.00% | ||
| +55.85% | ||
| +71.20% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.23 | ||
| $1.07 | ||
| SMA 200 vs Price | +373.21% | |
| $0.30 | ||
| SMA 50 vs Price | +33.04% | |
| 1.53 | ||
| $0.03 | ||
| 39.66 | ||
| 76.59% | ||
| 137.12% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.41M | ||
| -$1.79 | ||
| $0.00 | ||
| 46.49% | ||
| -$67.06M | ||
| -4,744.37% | ||
| -$62.42M | ||
| -4,416.34% | ||
| -$66.94M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.94 | ||
| 0.38 | ||
| 0.31 | ||
| - | ||
| - | ||
| -47.07 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 132.53 | ||
| -0.71 | ||
| -0.94 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$32.19M | ||
| $8.08M | ||
| $18.58M | ||
| $17.39M | ||
| $50.77M | ||
| $45.81M | ||
| $30.19M | ||
| $30.01M | ||
| $10.19M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $63.84M | ||
| $67.00M | ||
| $1.47M | ||
| $8.48M | ||
| $117.10K | ||
| $0.00 | ||
| -$1.55M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$51.83M | ||
| $0.00 | ||
| $44.99M | ||
| $0.00 | ||
| -$51.83M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Ascendiant Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Ascendiant Capital | → | |
| HC Wainwright & Co. | → | |
| Ascendiant Capital | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → |
Analyst sentiment
Institutional ownership
Screeners with OTLK
FAQ
What is the ticker symbol for Outlook Therapeutics, Inc.?
The ticker symbol for Outlook Therapeutics, Inc. is NASDAQ:OTLK
Does Outlook Therapeutics, Inc. pay dividends?
No, Outlook Therapeutics, Inc. does not pay dividends
What sector is Outlook Therapeutics, Inc. in?
Outlook Therapeutics, Inc. is in the Healthcare sector
What industry is Outlook Therapeutics, Inc. in?
Outlook Therapeutics, Inc. is in the Biotechnology industry
What country is Outlook Therapeutics, Inc. based in?
Outlook Therapeutics, Inc. is headquartered in United States
When did Outlook Therapeutics, Inc. go public?
Outlook Therapeutics, Inc. initial public offering (IPO) was on June 14, 2016
Is Outlook Therapeutics, Inc. in the S&P 500?
No, Outlook Therapeutics, Inc. is not included in the S&P 500 index
Is Outlook Therapeutics, Inc. in the NASDAQ 100?
No, Outlook Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Outlook Therapeutics, Inc. in the Dow Jones?
No, Outlook Therapeutics, Inc. is not included in the Dow Jones index
When was Outlook Therapeutics, Inc. last earnings report?
Outlook Therapeutics, Inc.'s most recent earnings report was on February 17, 2026
When does Outlook Therapeutics, Inc. report earnings?
The next expected earnings date for Outlook Therapeutics, Inc. is May 14, 2026
Data Sources & References
- OTLK Official Website www.outlooktherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1649989/000110465926016554/0001104659-26-016554-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1649989/000110465925123264/0001104659-25-123264-index.htm
- OTLK Profile on Yahoo Finance finance.yahoo.com/quote/OTLK
- OTLK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/otlk